Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-26-226574
Filing Date
2026-05-15
Accepted
2026-05-15 16:00:03
Documents
2
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 26682
2 EX-99.1 ck0000000000-ex99_1.pdf EX-99.1 64375
  Complete submission text file 0001193125-26-226574.txt   117377
Mailing Address 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142 617 868-1888
Flagship Pioneering, LLC (Filed by) CIK: 0001400240 (see all company filings)

EIN.: 752992246 | State of Incorp.: DE
Type: SCHEDULE 13G

Mailing Address 101 SOUTH STREET, SUITE 900 SOMERVILLE MA 02143
Business Address 101 SOUTH STREET, SUITE 900 SOMERVILLE MA 02143 888-469-0055
Generate Biomedicines, Inc. (Subject) CIK: 0002100782 (see all company filings)

EIN.: 831630228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-95695 | Film No.: 26986560
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)